TP53 and familial pancreatic carcinoma: To gain deeper insights into the impact of mutant p53 on phospholipid composition, we conducted a comprehensive analysis comparing lipid species that exhibited differential abundance upon silencing of the R172H and R270H variants in pancreatic cancer cells (Fig. 3A, B).